A Significant Metabolic and Radiological Response after a Novel Targeted MicroRNA-based Treatment Approach in Malignant Pleural Mesothelioma

Am J Respir Crit Care Med. 2015 Jun 15;191(12):1467-9. doi: 10.1164/rccm.201503-0461LE.

Authors

Steven C Kao^{1

2

3}, Michael Fulham^{3

4}, Kirby Wong⁴, Wendy Cooper^{3

4

5}, Himanshu Brahmbhatt⁶, Jennifer MacDiarmid⁶, Scott Pattison⁶, Jin Og Sagong¹, Yennie Huynh², Felicity Leslie², Nick Pavlakis^{3

7}, Stephen Clarke^{3

7}, Michael Boyer^{1

3}, Glen Reid^{2

3}, Nico van Zandwijk^{2

3}

Affiliations

¹ 1 Chris O'Brien Lifehouse Sydney, Australia.
² 2 Asbestos Diseases Research Institute Sydney, Australia.
³ 3 University of Sydney Sydney, Australia.
⁴ 4 Royal Prince Alfred Hospital Sydney, Australia.
⁵ 5 University of Western Sydney Sydney, Australia.
⁶ 6 EnGeneIC Ltd. Sydney, Australia.
⁷ 7 Royal North Shore Hospital Sydney, Australia.

PMID: 26075427
DOI: 10.1164/rccm.201503-0461LE

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Lung / diagnostic imaging
Lung Neoplasms / diagnostic imaging*
Lung Neoplasms / drug therapy*
Male
Mesothelioma / diagnostic imaging*
Mesothelioma / drug therapy*
Mesothelioma, Malignant
MicroRNAs / therapeutic use*
Middle Aged
Tomography, X-Ray Computed
Treatment Outcome

Substances

MicroRNAs